nach oben

Erschienen in:

31.01.2018

Clinical correlates and pharmacological management of Asian patients with concomitant diabetes mellitus and heart failure

verfasst von: Yvonne May Fen Chia, Tiew-Hwa Katherine Teng, Chanchal Chandramouli, Jonathan Yap, Michael MacDonald, Carolyn S. P. Lam

Erschienen in: Heart Failure Reviews | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Asia is the center of convergence of the twin epidemics of diabetes mellitus (DM) and heart failure (HF). The regional and ethnic diversity across Asia, along with a high prevalence of a young, lean diabetic phenotype, emphasizes the importance of targeted public health strategies that address the unique needs of Asian patients with DM and HF. This review discusses the epidemiology, clinical correlates, pharmacological management, and outcomes of Asian patients with concomitant DM and HF.

Omran AR (2005) The epidemiologic transition: a theory of the epidemiology of population change. 1971. Milbank Q 83(4):731–757. https://doi.org/10.1111/j.1468-0009.2005.00398.x CrossRefPubMedPubMedCentral

World population ageing 2015 (2015) United Nations. http://www.un.org/en/development/desa/population/theme/ageing/WPA2015.shtml. Accessed 26 June 2017

Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, Hu FB (2009) Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 301(20):2129–2140. https://doi.org/10.1001/jama.2009.726 CrossRefPubMed

Dans A, Ng N, Varghese C, Tai ES, Firestone R, Bonita R (2011) The rise of chronic non-communicable diseases in southeast Asia: time for action. Lancet 377(9766):680–689. https://doi.org/10.1016/S0140-6736(10)61506-1 CrossRefPubMed

Ramachandran A, Ma RC, Snehalatha C (2010) Diabetes in Asia. Lancet 375(9712):408–418. https://doi.org/10.1016/S0140-6736(09)60937-5 CrossRefPubMed

Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, Cavan D, Shaw JE, Makaroff LE (2017) IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 128:40–50. https://doi.org/10.1016/j.diabres.2017.03.024 CrossRefPubMed

WHO (2017) Cardiovascular diseases World Health Organization. http://wwwwhoint/mediacentre/factsheets/fs317/en/ Accessed 15 July 2017

IDF Diabetes Atlas (2015) International Diabetes Federation

De Groote P, Lamblin N, Mouquet F, Plichon D, McFadden E, Van Belle E, Bauters C (2004) Impact of diabetes mellitus on long-term survival in patients with congestive heart failure. Eur Heart J 25(8):656–662. https://doi.org/10.1016/j.ehj.2004.01.010 CrossRefPubMed

10.

Lam CSP (2015) Heart failure in Southeast Asia: facts and numbers. ESC Heart Fail 2(2):46–49. https://doi.org/10.1002/ehf2.12036 CrossRefPubMed

11.

Lam CS, Teng TK, Tay WT, Anand I, Zhang S, Shimizu W, Narasimhan C, Park SW, Yu CM, Ngarmukos T, Omar R, Reyes EB, Siswanto BB, Hung CL, Ling LH, Yap J, MacDonald M, Richards AM (2016) Regional and ethnic differences among patients with heart failure in Asia: the Asian sudden cardiac death in heart failure registry. Eur Heart J 37(41):3141–3153. https://doi.org/10.1093/eurheartj/ehw331 CrossRefPubMed

12.

Sakata Y, Shimokawa H (2013) Epidemiology of heart failure in Asia. Circ J 77(9):2209–2217. https://doi.org/10.1253/circj.CJ-13-0971 CrossRefPubMed

13.

Hu FB (2011) Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care 34(6):1249–1257. https://doi.org/10.2337/dc11-0442 CrossRefPubMedPubMedCentral

14.

Misra A, Ramchandran A, Jayawardena R, Shrivastava U, Snehalatha C (2014) Diabetes in South Asians. Diabet Med 31(10):1153–1162. https://doi.org/10.1111/dme.12540 CrossRefPubMed

15.

Ma RC, Chan JC (2013) Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States. Ann N Y Acad Sci 1281(1):64–91. https://doi.org/10.1111/nyas.12098 CrossRefPubMedPubMedCentral

16.

Nanditha A, Ma RCW, Ramachandran A, Snehalatha C, Chan JCN, Chia KS, Shaw JE, Zimmet PZ (2016) Diabetes in Asia and the Pacific: implications for the global epidemic. Diabetes Care 39(3):472–485. https://doi.org/10.2337/dc15-1536 CrossRefPubMed

17.

Hu SS, Kong LZ, Gao RL, Zhu ML, Wang W, Wang YJ, Wu ZS, Chen WW, Liu MB (2012) Outline of the report on cardiovascular disease in China, 2010. Biomed Environ Sci 25(3):251–256. https://doi.org/10.3967/0895-3988.2012.03.001 PubMed

18.

Bank IEM, Gijsberts CM, Teng T-HK, Benson L, Sim D, Yeo PSD, Ong HY, Jaufeerally F, Leong GKT, Ling LH, Richards AM, de Kleijn DPV, Dahlström U, Lund LH, Lam CSP (2017) Prevalence and clinical significance of diabetes in Asian versus White patients with heart failure. JACC Heart Fail 5(1):14–24. https://doi.org/10.1016/j.jchf.2016.09.015 CrossRefPubMed

19.

Takeuchi T, Nakao M, Nomura K, Yano E (2009) Association of metabolic syndrome with depression and anxiety in Japanese men. Diabetes Metab 35(1):32–36. https://doi.org/10.1016/j.diabet.2008.06.006 CrossRefPubMed

20.

Ramachandran A, Snehalatha C, Ma RC (2014) Diabetes in South-East Asia: an update. Diabetes Res Clin Pract 103(2):231–237. https://doi.org/10.1016/j.diabres.2013.11.011 CrossRefPubMed

21.

Whiting DR, Guariguata L, Weil C, Shaw J (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94(3):311–321. https://doi.org/10.1016/j.diabres.2011.10.029 CrossRefPubMed

22.

Forouhi NG, Merrick D, Goyder E, Ferguson BA, Abbas J, Lachowycz K, Wild SH (2006) Diabetes prevalence in England, 2001—estimates from an epidemiological model. Diabet Med 23(2):189–197. https://doi.org/10.1111/j.1464-5491.2005.01787.x CrossRefPubMed

23.

Ramachandran A, Snehalatha C, Shetty AS, Nanditha A (2012) Trends in prevalence of diabetes in Asian countries. World J Diabetes 3(6):110–117. https://doi.org/10.4239/wjd.v3.i6.110 CrossRefPubMedPubMedCentral

24.

Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB, American Heart Association Statistics C, Stroke Statistics S (2015) Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation 131(4):e29–322. https://doi.org/10.1161/CIR.0000000000000152 CrossRefPubMed

25.

Chaturvedi V, Parakh N, Seth S, Bhargava B, Ramakrishnan S, Roy A, Saxena A, Gupta N, Misra P, Rai S, Anand K, Pandav C, Sharma R, Prasad S (2016) Heart failure in India: the INDUS (INDia Ukieri Study) study. J Pract Cardiovasc Sci 2(1):28–35. https://doi.org/10.4103/2395-5414.182988 CrossRef

26.

Okamoto H, Kitabatake A (2003) The epidemiology of heart failure in Japan. Nihon Rinsho 61(5):709–714PubMed

27.

Rhee E-J (2015) Diabetes in Asians. Endocrinol Metab 30(3):263–269. https://doi.org/10.3803/EnM.2015.30.3.263 CrossRef

28.

Ramachandran A, Chamukuttan S, Shetty SA, Arun N, Susairaj P (2012) Obesity in Asia—is it different from rest of the world. Diabetes Metab Res Rev 28(Suppl 2):47–51. https://doi.org/10.1002/dmrr.2353 CrossRefPubMed

29.

Rajadurai J, Tse H-F, Wang C-H, Yang N-I, Zhou J, Sim D (2017) Understanding the epidemiology of heart failure to improve management practices: an Asia-Pacific perspective. J Cardiac Fail 23(4):327–339. https://doi.org/10.1016/j.cardfail.2017.01.004 CrossRef

30.

Teng T, Tay W, Yap J, Anand I, Zhang S, Shimizu W, Narasimhan C, Park S, Yu C, Ngarmukos T, Omar R, Reyes E, Siswanto B, Hung C, Ling L, Richards A, Lam C (2017) Ethnic and regional variation in diabetes among Asian patients with heart failure. Eur J Heart Fail 37:736

31.

Dokainish H, Teo K, Zhu J, Roy A, AlHabib KF, ElSayed A, Palileo-Villaneuva L, Lopez-Jaramillo P, Karaye K, Yusoff K, Orlandini A, Sliwa K, Mondo C, Lanas F, Prabhakaran D, Badr A, Elmaghawry M, Damasceno A, Tibazarwa K, Belley-Cote E, Balasubramanian K, Islam S, Yacoub MH, Huffman MD, Harkness K, Grinvalds A, McKelvie R, Bangdiwala SI, Yusuf S, Campos R, Chacón C, Cursack G, Diez F, Escobar C, Garcia C, Vilamajo OG, Hominal M, Ingaramo A, Kucharczuk G, Pelliza M, Rojas A, Villani A, Zapata G, Bourke P, Lanas F, Nahuelpan L, Olivares C, Riquelme R, Ai F, Bai X, Chen X, Chen Y, Gao M, Ge C, He Y, Huang W, Jiang H, Liang T, Liang X, Liao Y, Liu S, Luo Y, Lu L, Qin S, Tan G, Tan H, Wang T, Wang X, Wei F, Xiao F, Zhang B, Zheng T, Mendoza JLA, Anaya MB, Gomez E, de Salazar DIM, Quiroz F, Rodríguez MJ, Sotomayor MS, Navas AT, León MB, Montalvo LAF, Jaramillo ML, Patiño EP, Perugachi C, Trujillo Cruz F, Elmaghawry M, Wagdy K, Bhardwaj AK, Chaturvedi V, Gokhale GK, Gupta R, Honnutagi R, Joshi P, Ladhani S, Negi PC, Roy A, Reddy N, Abdullah A, Hassan MRA, Balasinga M, Kasim S, Tan WY, Yusoff K, Damasceno A, Banze R, Calua E, Novela C, Chemane J, Akintunde AA, Ansa V, Gbadamosi H, Karaye KM, Mbakwem A, Mohammed S, Nwafor E, Ojji D, Olunuga T, Sa'idu BOH, Umuerri E, Alcaraz J, Palileo-Villanueva L, Palomares E, Timonera MR, Badr A, Alghamdi S, Alhabib K, Almasood A, Alsaif S, Elasfar A, Ghabashi A, Mimish L, Bester F, Kelbe D, Klug E, Sliwa K, Tibarzawa K, Abdalla OE, Dimitri ME, Mustafa H, Osman O, Saad A, Mondo C (2017) Global mortality variations in patients with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study. Lancet Glob Health 5(7):e665–e672. https://doi.org/10.1016/S2214-109X(17)30196-1 CrossRefPubMed

32.

Guo Y, Lip GYH, Banerjee A (2013) Heart failure in East Asia. Curr Cardiol Rev 9(2):112–122. https://doi.org/10.2174/1573403X11309020004 CrossRefPubMedPubMedCentral

33.

Sellayah D, Cagampang FR, Cox RD (2014) On the evolutionary origins of obesity: a new hypothesis. Endocrinology 155(5):1573–1588. https://doi.org/10.1210/en.2013-2103 CrossRefPubMed

34.

Tillin T, Hughes AD, Mayet J, Whincup P, Sattar N, Forouhi NG, McKeigue PM, Chaturvedi N (2013) The relationship between metabolic risk factors and incident cardiovascular disease in Europeans, South Asians, and African Caribbeans: SABRE (Southall and Brent Revisited)—a prospective population-based study. J Am Coll Cardiol 61(17):1777–1786. https://doi.org/10.1016/j.jacc.2012.12.046 CrossRefPubMedPubMedCentral

35.

Shah A, Kanaya AM (2014) Diabetes and associated complications in the South Asian population. Curr Cardiol Rep 16(5):476–476. https://doi.org/10.1007/s11886-014-0476-5 CrossRefPubMedPubMedCentral

36.

Pardhan S, Gilchrist J, Mahomed I (2004) Impact of age and duration on sight-threatening retinopathy in South Asians and Caucasians attending a diabetic clinic. Eye (London, England) 18(3):233–240. https://doi.org/10.1038/sj.eye.6700629 CrossRef

37.

Dixon AN, Raymond NT, Mughal S, Rahim A, O'Hare JP, Kumar S, Barnett AH (2006) Prevalence of microalbuminuria and hypertension in South Asians and white Europeans with type 2 diabetes: a report from the United Kingdom Asian Diabetes Study (UKADS). Diab Vasc Dis Res 3(1):22–25. https://doi.org/10.3132/dvdr.2006.002 CrossRefPubMed

38.

Chandie Shaw PK, Baboe F, van Es LA, van der Vijver JC, van de Ree MA, de Jonge N, Rabelink TJ (2006) South-Asian type 2 diabetic patients have higher incidence and faster progression of renal disease compared with Dutch-European diabetic patients. Diabetes Care 29(6):1383–1385. https://doi.org/10.2337/dc06-0003 CrossRefPubMed

39.

Dreyer G, Hull S, Aitken Z, Chesser A, Yaqoob MM (2009) The effect of ethnicity on the prevalence of diabetes and associated chronic kidney disease. QJM 102(4):261–269. https://doi.org/10.1093/qjmed/hcn177 CrossRefPubMed

40.

Teng T, Tay W, Yan L, Tromp J, Anand I, Richards A, Yap J, Macdonald M, Ling L, Siswanto B, Liew H, Reyes E, Shimizu W, Zhang S, Narasimhan C, Yu C, Park S, Ngarmukos T, Hung C, Regensteiner J, Lam C (2017) Sex differences in diabetic patients from the ASIAN-HF registry. Eur J Heart Fail 19:470–470

41.

Cockram CS (2000) The epidemiology of diabetes mellitus in the Asia-Pacific region. Hong Kong Med J 6(1):43–52PubMed

42.

Abate N, Chandalia M (2007) Ethnicity, type 2 diabetes & migrant Asian Indians. Indian J Med Res 125(3):251–258PubMed

43.

Abate N, Chandalia M, Snell PG, Grundy SM (2004) Adipose tissue metabolites and insulin resistance in nondiabetic Asian Indian men. J Clin Endocrinol Metab 89(6):2750–2755. https://doi.org/10.1210/jc.2003-031843 CrossRefPubMed

44.

McKeigue PM, Pierpoint T, Ferrie JE, Marmot MG (1992) Relationship of glucose intolerance and hyperinsulinaemia to body fat pattern in South Asians and Europeans. Diabetologia 35(8):785–791. https://doi.org/10.1007/BF00429101 PubMed

45.

Barma P, Ranabir S, Prasad L, Singh T (2011) Clinical and biochemical profile of lean type 2 diabetes mellitus. Indian J Endocrinol Metabol 15(5):40–43. https://doi.org/10.4103/2230-8210.83061 CrossRef

46.

Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444(7121):840–846. https://doi.org/10.1038/nature05482 CrossRefPubMed

47.

Deurenberg-Yap M, Chew SK, Deurenberg P (2002) Elevated body fat percentage and cardiovascular risks at low body mass index levels among Singaporean Chinese, Malays and Indians. Obes Rev 3(3):209–215. https://doi.org/10.1046/j.1467-789X.2002.00069.x CrossRefPubMed

48.

Gustafsson I, Brendorp B, Seibaek M, Burchardt H, Hildebrandt P, Kober L, Torp-Pedersen C, Danish Investigatord of A, Mortality on Dofetilde Study G (2004) Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure. J Am Coll Cardiol 43(5):771–777. https://doi.org/10.1016/j.jacc.2003.11.024 CrossRefPubMed

49.

MacDonald MR, Jhund PS, Petrie MC, Lewsey JD, Hawkins NM, Bhagra S, Munoz N, Varyani F, Redpath A, Chalmers J, MacIntyre K, McMurray JJ (2008) Discordant short- and long-term outcomes associated with diabetes in patients with heart failure: importance of age and sex: a population study of 5.1 million people in Scotland. Circ Heart Fail 1(4):234–241. https://doi.org/10.1161/circheartfailure.108.794008 CrossRefPubMed

50.

Mosterd A, Cost B, Hoes AW, de Bruijne MC, Deckers JW, Hofman A, Grobbee DE (2001) The prognosis of heart failure in the general population: the Rotterdam study. Eur Heart J 22(15):1318–1327. https://doi.org/10.1053/euhj.2000.2533 CrossRefPubMed

51.

Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJ, Swedberg KB, Ostergren J, Michelson EL, Pieper KS, Granger CB (2006) Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 27(1):65–75. https://doi.org/10.1093/eurheartj/ehi555 CrossRefPubMed

52.

Domanski M, Krause-Steinrauf H, Deedwania P, Follmann D, Ghali JK, Gilbert E, Haffner S, Katz R, Lindenfeld J, Lowes BD, Martin W, McGrew F, Bristow MR, Investigators B (2003) The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial. J Am Coll Cardiol 42(5):914–922. https://doi.org/10.1016/S0735-1097(03)00856-8 CrossRefPubMed

53.

Suskin N, McKelvie RS, Burns RJ, Latini R, Pericak D, Probstfield J, Rouleau JL, Sigouin C, Solymoss CB, Tsuyuki R, White M, Yusuf S (2000) Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. Eur Heart J 21(16):1368–1375. https://doi.org/10.1053/euhj.1999.2043 CrossRefPubMed

54.

Kaneko H, Suzuki S, Goto M, Arita T, Yuzawa Y, Yagi N, Murata N, Kato Y, Kano H, Matsuno S, Otsuka T, Uejima T, Oikawa Y, Sagara K, Nagashima K, Kirigaya H, Sawada H, Aizawa T, Yajima J, Yamashita T (2015) Incidence and predictors of rehospitalization of acute heart failure patients. Int Heart J 56(2):219–225. https://doi.org/10.1536/ihj.14-290 CrossRefPubMed

55.

Lee R, Chan S-P, Wong J, Lau D, Ho K-T, Ng K (2010) Impact of diabetes mellitus on survival in South East Asian patients with congestive heart failure due to left ventricular systolic dysfunction. Int J Cardiol 142(1):97–100. https://doi.org/10.1016/j.ijcard.2008.11.139 CrossRefPubMed

56.

Huxley RR, Barzi F, Woo J, Giles G, Lam TH, Rahimi K, Konety S, Ohkubo T, Jee SH, Fang X, Woodward M (2014) A comparison of risk factors for mortality from heart failure in Asian and non-Asian populations: an overview of individual participant data from 32 prospective cohorts from the Asia-Pacific region. BMC Cardiovasc Disord 14(1):61. https://doi.org/10.1186/1471-2261-14-61 CrossRefPubMedPubMedCentral

57.

Marathe PH, Gao HX, Close KL (2017) American Diabetes Association Standards of Medical Care in Diabetes 2017. J Diabetes 9(4):320–324. https://doi.org/10.1111/1753-0407.12524 CrossRefPubMed

58.

Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18(8):891–975. https://doi.org/10.1002/ejhf.592 CrossRefPubMed

59.

Ko S-H, Kim D-J, Park J-H, Park C-Y, Jung CH, Kwon H-S, Park J-Y, Song K-H, Han K, Lee K-U, Ko K-S (2016) Trends of antidiabetic drug use in adult type 2 diabetes in Korea in 2002–2013: nationwide population-based cohort study. Medicine 95(27):e4018. https://doi.org/10.1097/MD.0000000000004018 CrossRefPubMedPubMedCentral

60.

Ou HT, Chang KC, Liu YM, Wu JS (2017) Recent trends in the use of antidiabetic medications from 2008 to 2013: a nation-wide population-based study from Taiwan. J Diabetes 9(3):256–266. https://doi.org/10.1111/1753-0407.12408 CrossRefPubMed

61.

Chia Y, T T, Tay W, Tromp J, Richards A, Ling L, Shimizu W, Park S, Hung C, Ngarmukos T, Liew H, Zhang S, Narasimhan C, Siswanto B, Reyes E, Yu C, Anand I, Yap J, Macdonald M, Lam C (2017) Prescription of anti-diabetic-glucose-lowering agents and clinical outcomes in asian patients with heart failure and type 2 diabetes mellitus. Eur J Heart Fail 19:292–292

62.

Fitchett D, Zinman B, Wanner C, Lachin JM, Hantel S, Salsali A, Johansen OE, Woerle HJ, Broedl UC, Inzucchi SE (2016) Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial. Eur Heart J 37(19):1526–1534. https://doi.org/10.1093/eurheartj/ehv728 CrossRefPubMedPubMedCentral

63.

Kaku K, Lee J, Mattheus M, Kaspers S, George J, Woerle H-J, on behalf of the E-REGOI (2017) Empagliflozin and cardiovascular outcomes in Asian patients with type 2 diabetes and established cardiovascular disease―results from EMPA-REG OUTCOME®―. Circ J 81(2):227–234. https://doi.org/10.1253/circj.CJ-16-1148 CrossRefPubMed

64.

Fung CSC, Wan EYF, Wong CKH, Jiao F, Chan AKC (2015) Effect of metformin monotherapy on cardiovascular diseases and mortality: a retrospective cohort study on Chinese type 2 diabetes mellitus patients. Cardiovasc Diabetol 14(1):137. https://doi.org/10.1186/s12933-015-0304-2 CrossRefPubMedPubMedCentral

65.

Kankanala SR, Syed R, Gong Q, Ren B, Rao X, Zhong J (2016) Cardiovascular safety of dipeptidyl peptidase-4 inhibitors: recent evidence on heart failure. Am J Transl Res 8(5):2450–2458PubMedPubMedCentral

66.

Hippisley-Cox J, Coupland C (2016) Diabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary care. BMJ 354. https://doi.org/10.1136/bmj.i3477

Titel: Clinical correlates and pharmacological management of Asian patients with concomitant diabetes mellitus and heart failure
verfasst von: Yvonne May Fen Chia
Tiew-Hwa Katherine Teng
Chanchal Chandramouli
Jonathan Yap
Michael MacDonald
Carolyn S. P. Lam
Publikationsdatum: 31.01.2018
Verlag: Springer US
Erschienen in: Heart Failure Reviews / Ausgabe 3/2018
Print ISSN: 1382-4147
Elektronische ISSN: 1573-7322
DOI: https://doi.org/10.1007/s10741-018-9672-5

Neu im Fachgebiet Kardiologie

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2018

Possible mechanisms of direct cardiovascular impact of GLP-1 agonists and DPP4 inhibitors

Clinical impact of oral antidiabetic medications in heart failure patients

Interdisciplinary approach to compensation of hypoglycemia in diabetic patients with chronic heart failure

Direct cardiovascular impact of SGLT2 inhibitors: mechanisms and effects